Method for imaging biologic fluid samples using a predetermined distribution

US2018156773A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2018156773-A1
Application numberUS-201815886324-A
CountryUS
Kind codeA1
Filing dateFeb 1, 2018
Priority dateDec 6, 2012
Publication dateJun 7, 2018
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method for analyzing a biologic fluid sample includes the steps of: a) providing a spatially mapped chamber; b) providing a predetermined repeatable non-uniform spatial distribution of one or more constituents within the sample, which distribution indicates the presence or absence of a statistically significant number of constituents within the sample in each chamber sub-region; c) selecting one or more image techniques for each sub-region based on the presence or absence of the statistically significant number of one or more constituents in that sub-region as indicated by the distribution; d) creating image data representative of the biologic fluid sample in each sub-region, using the one or more image techniques selected for that sub-region; and e) analyzing the sample.

First claim

Opening claim text (preview).

What is claimed is: 1 . A method for imaging a biologic fluid sample having one or more constituents, which sample is quiescently disposed within an analysis chamber, comprising: spatially mapping a biologic fluid sample quiescently residing within an analysis chamber, which biologic fluid sample includes one or more constituents, the spatial mapping defining a plurality of sub-regions; providing a predetermined repeatable non-uniform spatial distribution representative of at least one constituent within the biologic fluid sample quiescently residing within the analysis chamber, wherein the distribution indicates a presence or absence of the at least one constituent residing in select one or more sub-regions of the spatially mapped biologic fluid sample quiescently residing within the analysis chamber; selecting at least one imaging method for imaging the select one or more sub-regions based on the presence or absence of the at least one constituent in the select one or more sub-regions as indicated by the distribution; and creating image data representative of the biologic fluid sample in the select one or more sub-regions, using the at least one imaging method. 2 . The method of claim 1 , wherein the biologic fluid sample is blood and the constituents include at least one of white blood cells, red blood cells, plasma, or sphered red blood cells. 3 . The method of claim. 1 , wherein the chamber is a microscope slide. 4 . The method of claim 1 , wherein the step of creating image data representative of the biologic fluid sample in the select one or more sub-regions includes creating image data representative of the biologic fluid sample in all sub-regions. 5 . The method of claim 1 , wherein the predetermined repeatable non-uniform spatial distribution of at least one constituent within the biologic fluid sample quiescently residing within the analysis chamber indicates a plurality of sub-regions where white blood cells are likely present. 6 . The method of claim 1 , wherein the predetermined repeatable non-uniform spatial distribution of at least one constituent within the biologic fluid sample quiescently residing within the analysis chamber indicates a plurality of sub-regions where red blood cells are likely present. 7 . The method of claim 1 , further comprising analyzing the biologic fluid sample, using the image data representative of the biologic fluid sample in the select one or more sub-regions. 8 . The method of claim 1 , wherein the predetermined repeatable non-uniform spatial distribution representative of the at least one constituent within the biologic fluid sample quiescently residing within the analysis chamber in the select one or more sub-regions is based on empirical data. 9 . An apparatus for imaging a biologic fluid sample within a chamber configured to quiescently hold the biologic fluid sample, the apparatus comprising: at least one sample illuminator; at least one image dissector; and a processor in communication with the at least one sample illuminator, the at least one image dissector, and a non-transitory memory storing instructions, which instructions include a predetermined repeatable non-uniform spatial distribution representative of at least one constituent within the biologic fluid sample quiescently disposed within the chamber, wherein the spatial distribution indicates a presence or an absence of the at least one constituent residing in particular sub-regions of the biologic fluid sample quiescently residing within the chamber, and when executed the instructions cause the processor to: spatially map the biologic fluid sample quiescently residing within the analysis chamber, the spatial mapping defining the sub-regions of the biologic fluid sample quiescently residing within the chamber; select at least one imaging method for imaging select one or more of the sub-regions based on the presence or absence of the at least one constituent in the select sub-regions as indicated by the distribution; control the sample illuminator and the image dissector to create image data representative of the biologic fluid sample in the select one or more sub-regions, using the at least one imaging method. 10 . The apparatus of claim 9 , wherein the chamber is a microscope slide. 11 . The apparatus of claim 9 , wherein the predetermined repeatable non-uniform spatial distribution representative of the at least one constituent within the biologic fluid sample quiescently disposed within the chamber indicates a plurality of sub-regions where white blood cells are likely present. 12 . The apparatus of claim 9 , wherein the predetermined repeatable non-uniform spatial distribution representative of the at least one constituent within the biologic fluid sample quiescently disposed within the chamber indicates a plurality of sub-regions where red blood cells are likely present. 13 . The apparatus of claim 9 , wherein the biologic fluid sample is blood and the constituents include at least one of white blood cells, red blood cells, plasma, or sphered red blood cells. 14 . The apparatus of claim 9 , wherein the predetermined repeatable non-uniform spatial distribution representative of the at least one constituent within the biologic fluid sample quiescently residing within the analysis chamber in the select one or more sub-regions is based on empirical data.

Assignees

Inventors

Classifications

  • G01N33/49Primary

    Blood {(chemical methods for determining blood cell populations G01N33/5094; chemical analysis of blood groups or blood types G01N33/80)} · CPC title

  • Physical analysis of biological material · CPC title

  • Fluorescence microscopy (fluorescence microscopes per se G02B21/0076 and G02B21/16) · CPC title

  • using imaging; using holography · CPC title

  • Physics · mapped topic

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2018156773A1 cover?
A method for analyzing a biologic fluid sample includes the steps of: a) providing a spatially mapped chamber; b) providing a predetermined repeatable non-uniform spatial distribution of one or more constituents within the sample, which distribution indicates the presence or absence of a statistically significant number of constituents within the sample in each chamber sub-region; c) selecting …
Who is the assignee on this patent?
Abbott Point Of Care Inc
What technology area does this patent fall under?
Primary CPC classification G01N33/49. Mapped technology areas include Physics.
When was this patent published?
Publication date Thu Jun 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).